Health Promotion and Disease Prevention Research Center

健康促进与疾病预防研究中心

• 批准号: 8845691
• 负责人: CHAU TRINH-SHEVRIN
• 金额: $ 15万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-09-30 至 2019-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8845691
• 关键词: Health; Promotion; Disease; Prevention; Research

 DESCRIPTION (provided by applicant): Alzheimer's disease and related disorders (AD) affects 5.6 million Americans regardless of racial, ethnic or cultural background, presenting a significant public health challenge that will only increase with aging of the US population. By 2050, the US Census Bureau estimates that over one-fifth of the US population will be 65 and older. The greatest rate of increase will be experienced in the most vulnerable group those 85 and older. In 2000, this population represented 1.5% of the US population; by 2050, they will comprise almost 5%. Each, with each person with dementia is estimated to have 2.9 family caregivers. Little attention has been placed on the role and impact of cultural beliefs and sociodemographic factors (age, gender, education, language, race, ethnicity) on the patient's and families' understanding of the signs, symptoms, causes, treatment or management of AD, their disease experiences, or how these factors influence health outcomes. Much AD caregiving research has been done in Caucasian populations; by 2050 it is estimated that the proportion of elder Americans who are African American, Hispanic, or Asian American will increase to 39%. To effectively attend to the AD epidemic we address SIP-14-003 with the following OBJECTIVES: (a) develop evidence- based public health messages about cognitive health and impairment that resonate with diverse populations of older adults and their families, their health care providers, and policy makers; (b) determine the most effective ways to disseminate these messages; and (c) translate these messages into health promotion and prevention programs that promote risk reduction, facilitate early detection, diagnosis and treatment, and increase participation in AD clinical research. To achieve our objectives, we propose the following activities: 1) Perform a scoping review and create a compendium of facilitators and barriers; 2) Conduct and analyze results from 4 focus groups of AD patients from diverse backgrounds and 4 focus groups with their family caregiver; 3) Convene a Stakeholder Advisory Coalition to provide expert guidance and insight; 4) Leverage city- and state- wide connections and disseminate the findings and the compendium to the public health and clinical research networks; and 5) Evaluate effectiveness of dissemination and community translation approaches. This application has the potential to have sustained influence on the evidence-based messages for improved public health practice. Furthermore, our cross-cultural approach can be generalized for broader implementation.

 描述（由申请人提供）：阿尔茨海默病和相关疾病（AD）影响560万美国人，无论种族、民族或文化背景如何，这是一个重大的公共卫生挑战，只会随着美国人口的老龄化而增加。到2050年，美国人口普查局估计，超过五分之一的美国人口将超过65岁。最易受伤害群体的增长率最高 85岁以上的人在2000年，这一人口占美国人口的1.5%;到2050年，他们将占近5%。每个痴呆症患者估计有2.9个家庭照顾者。很少有人关注文化信仰和社会人口因素（年龄、性别、教育、语言、种族、民族）对患者和家属理解AD的体征、症状、病因、治疗或管理、他们的疾病经历或这些因素如何影响健康结果的作用和影响。在高加索人群中进行了大量的AD研究;据估计，到2050年，非洲裔美国人，西班牙裔美国人或亚裔美国人的老年人比例将增加到39%。为了有效地应对AD流行病，我们采用以下方法解决SIP-14-003：（a）制定关于认知健康和障碍的循证公共卫生信息，这些信息与不同人群的老年人及其家人、他们的卫生保健提供者和政策制定者产生共鸣;（B）确定传播这些信息的最有效方式;以及（c）将这些信息转化为健康促进和预防计划，以促进降低风险，促进早期发现，诊断和治疗，并增加对AD临床研究的参与。为了实现我们的目标，我们提出了以下活动：1）进行范围审查，并创建一个促进者和障碍的纲要; 2）进行和分析来自不同背景的AD患者的4个焦点小组和4个焦点小组与他们的家庭照顾者的结果; 3）召集利益相关者咨询联盟，提供专家指导和见解; 4）利用城市和州范围的联系，将研究结果和纲要传播给公共卫生和临床研究网络; 5）评估传播和社区翻译方法的有效性。这一应用有可能对改善公共卫生实践的循证信息产生持续影响。此外，我们的跨文化方法可以推广到更广泛的实施。